Experience

Boustead & Company Limited

• United States
• Financial Services
• 1 - 100 Employee

• Senior Advisor

  • 2019 - Present

  Boustead Securities is an investment banking firm that advises clients on mergers and acquisitions, capital raises and restructuring in a wide array of industries and circumstances. Boustead Securities is an investment banking firm that advises clients on mergers and acquisitions, capital raises and restructuring in a wide array of industries and circumstances.



Mainz Biomed

• Germany
• Biotechnology Research
• 1 - 100 Employee

• Independent Director (Board of Directors)

  • Nov 2021 - Present

  Mainz Biomed (NASDAQ: MYNZ) develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company’s flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection diagnostic test for colorectal cancer. ColoAlert is currently marketed across Europe with an FDA clinical study and submission process intended to be launched in the first half of 2022 for U.S. regulatory approval. Mainz Biomed’s product candidate portfolio includes PancAlert, an early-stage pancreatic cancer screening test based on Real-Time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples, and the GenoStick technology, a platform being developed to detect pathogens on a molecular genetic basis. Show less



Brera Holdings PLC

• Ireland
• Sports Teams and Clubs
• 1 - 100 Employee

• Independent Director (Board of Directors)

  • Jul 2022 - Present

  Brera Holdings PLC (Nasdaq: BREA) is an Irish holding company focused on expanding social impact football (American soccer) by developing a global portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services. The Company seeks to build on the legacy and brand of Brera FC, the first football club that was acquired by the Company. Brera FC, known as “The Third Team of Milan,” is an amateur football association which has been building an alternative football legacy since its founding in 2000. The Company is focused on bottom-up value creation from sports clubs and talent outside mainstream markets, innovation-powered business growth, and socially-impactful outcomes. Show less



M Ventures

• Netherlands
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Investment Fellow

  • 2019 - 2020

  Strategic, CVC arm of Merck KGaA pharma, looking at disruptive and innovative technologies with the potential to impact Merck‘s core business areas. Investment fields include Biopharmaceuticals, Life Sciences, Advanced Materials and Future Tech. Strategic, CVC arm of Merck KGaA pharma, looking at disruptive and innovative technologies with the potential to impact Merck‘s core business areas. Investment fields include Biopharmaceuticals, Life Sciences, Advanced Materials and Future Tech.



Atelier Mnemist SAS

• Paris Area, France

• Co-founder and Managing Director

  • 2016 - 2019

  Atelier Mnemist - a start-up brand whose patent-pending technology enables personalised fragrance creation through the means of AI and robotics. Rasied public and private capital. BPI Bourse French Tech 2017 Winner. Housed @ EU-backed BGE-Parif GEAI incubator. Atelier Mnemist - a start-up brand whose patent-pending technology enables personalised fragrance creation through the means of AI and robotics. Rasied public and private capital. BPI Bourse French Tech 2017 Winner. Housed @ EU-backed BGE-Parif GEAI incubator.



L'Oréal

• France
• Personal Care Product Manufacturing
• 700 & Above Employee

• Business Development & Licensing Manager

  • 2012 - 2015

  Overviewing worldwide R&D business development opportunities and tech transfer needs for L'Oréal. Negotiating 50+ licensing and R&D collaborative deals. Due diligence for tech-centric M&A deals. Portfolio and project proposal assessment: analysis and evaluation of IP-strength, financial positioning, tech-evaluation and industry pertinence. Worked closely with Connected Beauty Incubator. Overviewing worldwide R&D business development opportunities and tech transfer needs for L'Oréal. Negotiating 50+ licensing and R&D collaborative deals. Due diligence for tech-centric M&A deals. Portfolio and project proposal assessment: analysis and evaluation of IP-strength, financial positioning, tech-evaluation and industry pertinence. Worked closely with Connected Beauty Incubator.



Novartis

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Investment Analyst

  • 2011 - 2012

  NVF is a leading, stage agnostic VC, engaging in investments from seed- to later-stage life sciences companies across the biotechnology and biopharma sectors. Work heavily focused on VC opportunities in China. NVF is a leading, stage agnostic VC, engaging in investments from seed- to later-stage life sciences companies across the biotechnology and biopharma sectors. Work heavily focused on VC opportunities in China.